FindTrial
Sign In

Looking at the Link Between Weight and Metabolism in Women After Menopause

Assessment Of Metabolic Profile Of Post-menopausal Women In Relation To Obesity

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/05/111365
Enrollment
60
Registered
2026-05-29
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil Intervention3: Nil: Nil

Sponsors

Bharati Vidyapeeth (Deemed to be University)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: a.Apparently healthy postmenopausal women in the age group 40-60 years with BMI: 18 - 34.9 kg/m2 b.Women within 3 years of natural menopause where menopause is defined as less than or equal to 12 months of spontaneous amenorrhea. c.Women willing to provide written informed consent and comply with study procedures.

Exclusion criteria

Exclusion criteria: a.Women with surgical menopause (history of hysterectomy with or without oophorectomy). b.Women receiving hormone replacement therapy (HRT) or hormonal medications within the past six months. c.Women with known history of diabetes mellitus, cardiovascular disease, thyroid disorders, or other diagnosed endocrine disorders, chronic inflammatory conditions, autoimmune diseases, or severe musculoskeletal/neurological conditions limiting participation in functional assessments. e.Women currently on medications known to significantly affect metabolic, hormonal, or inflammatory parameters (e.g., systemic corticosteroids, insulin, oral hypoglycemics). Women with psychiatric illnesses or cognitive impairment affecting reliable questionnaire-based assessment.

Design outcomes

Primary

MeasureTime frame
1. Body Composition & Anthropometry a. Sagittal abdominal diameter b. Body fat composition c. Neck circumference 2. Biochemical parameters a. Lipid Profile b. Glucose Profile i. Glycated Haemoglobin ii. Fasting Insulin iii. Fasting Blood GlucoseTimepoint: Baseline—

Secondary

MeasureTime frame
1. Biochemical parameters a. Hormonal Parameters i. Estradiol ii. Testosterone iii. Cortisol iv. Insulin-like Growth Factor (IGF)-1 b. Inflammatory marker i. High sensitivity C-Reactive Protein 2. Muscle Strength a. Handgrip strength b. Muscle strength assessment 3. Psychological Parameters a. Depression, Anxiety and Stress Scale - 21 (DASS-21) b. Pittsburgh Sleep Quality Index (PSQI) c. Menopause-Specific Quality of Life (MENQoL) Timepoint: Baseline—

Countries

India

Contacts

Public ContactDr Revati Bhat

Bharati Vidyapeeth (Deemed to be University), Interactive Research School for Health Affairs

revatibhat@bharatividyapeeth.edu9860258443

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026